Oncotarget is one of the leading journals in the field of oncology, focusing on new and viable cancer treatments. Dr. Irfan Rahman, a professor at the University of Rochester School of Medicine recently published a paper in Oncotarget presenting findings suggesting that use of e-cigarettes may be hazardous. Despite being touted as a panacea for smokers looking to quit on LinkedIn, this research indicates that those who substitute e-cigarettes for tobacco are not necessarily making a completely safe choice.
The research on scimagojr.com also suggests that flavorings in e-cigarettes increase the risk of problems in the mouth and gums, and that the amount of use is positively correlated with a higher risk of disease. Just like regular cigarettes, e-cigarettes contain nicotine, which is known to be a contributing factor in gum disease. Dr. Rahman argues that this is even more evidence suggesting that the ill effects of smoking are not completely linked to the chemicals they contain. In fact, the article makes the startling claim that e-cigarettes are just as harmful to the mouth and gums as regular cigarettes.
Founded in 2010, the journal is edited by Mikhail Blagosklonny and Andrei V. Gudkov of Roswell Park Cancer Institute in Buffalo, New York. It is an interdisciplinary journal seeking to break down the walls between different sub-fields in bio-medicine and molecular research in oncology. The publication is indexed by all of the major journal repositories in medicine, such as MEDLINE and PubMed. Published by Impact Journals, Oncotarget currently holds an impact factor rating of 5.415 and is received the highest rating, Q1, in Scopus/SJR.